Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | mBTCvax |
| Synonyms | |
| Therapy Description |
mBTCvax is a personalized cancer vaccine comprising patient tumor-derived neoantigen peptides combined with poly-ICLC, which may induce a cytotoxic T-lymphocyte (CTL) response against tumor cells (NCI Drug Dictionary) |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| mBTCvax | mBTCvax is a personalized cancer vaccine comprising patient tumor-derived neoantigen peptides combined with poly-ICLC, which may induce a cytotoxic T-lymphocyte (CTL) response against tumor cells (NCI Drug Dictionary) |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|